News | July 8, 2011

Chiltern Announces New Legal Entity In Israel

London /PRNewswire/ -- Chiltern International Limited (Chiltern), a global clinical contract research organization (CRO), announced that the company has established a new legal entity in Israel.

"Chiltern has experienced a healthy number of requests from our clients in this region and forming a legal entity is a natural progression to our work there," commented Armand Czaplinski, Chiltern's Executive Director, Global Country Management, who will be leading the effort in Israel. "Israel is an attractive location to conduct clinical trials as it has many key opinion leaders (KOL) in clinical research and outstanding quality of research. Israel has some of the most skilled and educated work forces with the highest number of doctors, scientists and engineers per capita than any other country. Another key advantage is that the majority of Israel's population belongs to the same health maintenance organization and this facilitates quick start for clinical trials and reduces the overall project timelines."

Glenn Kerkhof, Chiltern CEO, stated, "We are delighted to add Israel to our established global footprint to better serve our clients. It is essential for Chiltern to have operations in Israel to tap into the renowned clinical research expertise, experienced investigators and key opinion leaders available in this country."

Company profile

About Chiltern:
Established in 1982, Chiltern is a leading global clinical CRO with extensive experience in the management of Phase I-IV clinical trials across a broad range of therapeutic areas, functional service provision and contract staffing solutions. Chiltern has conducted trials in more than 40 countries, employs nearly 1,300 people globally and offers services in Early Phase, Global Clinical Development, Late Phase, Biometrics, Medical and Regulatory Affairs and Resourcing Solutions. Chiltern prides itself as a development partner that offers flexibility, responsiveness and quality delivery. Further information is available at: www.chiltern.com.

SOURCE Chiltern

Copyright 2011 PR Newswire. All Rights Reserved